Risk of pneumonitis in cancer patients treated with immune checkpoint inhibitors: a meta-analysis
Conclusions:
Our analysis provided evidence that the use of immune checkpoint inhibitors is associated with an increased risk of all-grade pneumonitis compared with chemotherapy or placebo controls.
Source: Therapeutic Advances in Respiratory Disease - Category: Respiratory Medicine Authors: Abdel-Rahman, O., Fouad, M. Tags: Original Research Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Lung Cancer | Respiratory Medicine | Yervoy